Document is current
Any future updates will be listed below
-
Authors
,
He, Hongyong http://orcid.org/0000-0001-7371-4133
Li, Haojie
Su, Xiangqian
Li, Ziyu
Yu, Peiwu
Huang, Hua
Huang, Changming
Ye, Jianxin
Li, Yong
Suo, Jian
Yu, Jiren
Li, Guoxin
Xu, Zekuan
Zhao, Gang
Cao, Hui
Hu, Jiankun
Du, Xiaohui
Liu, Fenglin
Sun, Yihong
-
Funding
Funding for this research was provided by:
Clinical Trial Fund of Zhongshan Hospital (2016ZSLC13)
- License Information
-
More Information
Article History
Received: 21 September 2017
Accepted: 21 September 2018
First Online: 3 October 2018
Ethics approval and consent to participate
: Before enrollment of first patient, this study was approved from the institutional review boards of all research centers (14 tertiary hospitals) in China, including Zhongshan Hospital Fudan University (B2016-160R), Beijing Cancer Hospital, Southwest Hospital, Fudan University Shanghai Cancer Center, Fujian Medical University Union Hospital, The First Affiliated Hospital of Fujian Medical University, Guangdong General Hospital, The First Bethune Hospital of Jilin University, The First Affiliated Hospital Zhejiang University, Nangfang Hospital, The First Affiliated Hospital With Nanjing Medical University, Renji Hospital, West China Hospital, Sichuan University, and Chinese PLA General Hospital. Written informed consent will be obtained from all patients for the acquisition and use of anonymized clinical data before they are recruited.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
